Park Jun Yeon, Shin Myoung-Sook
Department of Food Science and Biotechnology, Kyonggi University, Suwon-si, Gyeonggi-do 16227, Korea.
College of Korean Medicine, Gachon University, Seongnam-si, Gyeonggi-do 13120, Korea.
Polymers (Basel). 2020 Dec 26;13(1):64. doi: 10.3390/polym13010064.
Persimmon leaves are an attractive source of phytochemicals with potential health benefits. However, there are only a few reports on the chemical properties and biological activity of the polysaccharide fractions (PLE-I-III) of persimmon leaves. We evaluated the angiogenesis-inhibiting ability of pectic-polysaccharides. The molecular weight of PLEs was determined using a high-performance size-exclusion chromatography system. Tube formation assay of human umbilical vein endothelial cells (HUVECs) was performed using Matrigel-coated 96-well plates. Matrix metalloproteinase (MMP-9), vascular endothelial growth factor (VEGF), PI3K, Akt, and p38 phosphorylation levels were determined using Western blotting; VEGF and MMP-9 transcript levels were measured using SYBR Green qRT-PCR. PLE-I-III significantly inhibited HUVEC tube formation at 12.5 and 25 μg/mL. Among them, PLE-II showed the strongest anti-tube formation activity, and the mRNA/protein expression of angiogenesis-related factors (VEGF/MMP-9) was significantly reduced by PLE-II. PLE-II also suppressed the phosphorylation of PI3K/AKT and p38, JNK, and NF-κB p65 in HUVECs. These results suggest that the polysaccharide PLE-II isolated from persimmon leaves inhibited VEGF and MMP-9 expression in HUVECs via regulation of PI3K/AKT, p38, JNK, and NF-κB p65 signaling pathways.
柿子叶是一种富含植物化学物质的诱人来源,对健康具有潜在益处。然而,关于柿子叶多糖组分(PLE-I-III)的化学性质和生物活性的报道却很少。我们评估了果胶多糖的血管生成抑制能力。使用高效尺寸排阻色谱系统测定了PLEs的分子量。使用基质胶包被的96孔板对人脐静脉内皮细胞(HUVECs)进行管形成试验。使用蛋白质免疫印迹法测定基质金属蛋白酶(MMP-9)、血管内皮生长因子(VEGF)、PI3K、Akt和p38的磷酸化水平;使用SYBR Green qRT-PCR测量VEGF和MMP-9的转录水平。PLE-I-III在12.5和25μg/mL时显著抑制HUVEC管形成。其中,PLE-II表现出最强的抗管形成活性,并且PLE-II显著降低了血管生成相关因子(VEGF/MMP-9)的mRNA/蛋白表达。PLE-II还抑制了HUVECs中PI3K/AKT以及p38、JNK和NF-κB p65的磷酸化。这些结果表明,从柿子叶中分离出的多糖PLE-II通过调节PI3K/AKT、p38、JNK和NF-κB p65信号通路抑制了HUVECs中VEGF和MMP-9的表达。